Publication: 4215

Publication: 4215

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Immunother Cancer vol 12 (9)

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 15

Parents:: 3248
Children:: None

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA232760, UG1CA233180, UG1CA233290, UG1CA233331, UG1CA233339, P30 CA08748

Corr. Author:
Authors:: Nathan D Seligson James L Chen Austin C Goodrich Brian A Van Tine Jordan D Campbell Allison L Richards Cristina R Antonescu David A Liebner Mohammed M Milhem Howard Streicher William D Tap Gary K Schwartz Suzanne George Sandra P D'Angelo

Networks:: COLUMBIA, IA018, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-OH007

Study: Alliance-A091401-ST1
Multiple Studies, or Legacy Studies in Alliance Study:: Alliance-A151810, Alliance-A151927
Phases:: N/A, N/A

Keywords: